DailyDoctor Archive Specialties Get app
Back to the 22 October 2026 edition

Pearl · 05 of 06

Double the PSA on a 5-alpha reductase inhibitor

Double the PSA in men on 5-alpha reductase inhibitors, and treat any rise from the nadir as suspicious.

Finasteride and dutasteride lower serum PSA by roughly half after about six months of treatment. A PSA that looks normal in a man on these drugs may therefore hide a rising true value. The common rule of thumb is to double the measured PSA to estimate the untreated level, and more importantly, to treat any confirmed rise from the on-treatment nadir as suspicious. Record whether a man is taking one of these drugs when interpreting PSA, and remember they are also prescribed for hair loss, so ask specifically.

  • Ask every man having a PSA test whether he takes finasteride or dutasteride, including for hair loss.
  • Roughly double the PSA after six months on treatment to estimate the untreated value.
  • Investigate any confirmed rise from the on-treatment nadir.
  • Record a baseline PSA before starting a 5-alpha reductase inhibitor where possible.

Why it matters

A falsely reassuring PSA is a common route to a delayed prostate cancer diagnosis.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

prostatecancer

Tomorrow morning, before your first patient

One edition a day for urology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app